Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany (vol 102, pg 351, 2023)-MedSci.cn

Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany (vol 102, pg 351, 2023)

Dittrich, AS; Dumke, M; Kapl, F; Schneider, P; Wege, S; Gräber, S; Stahl, M; Herth, FJ; Naehrlich, L; Mall, MA; Sommerburg, O; German CF Registry

RESPIRATION, 2023; 102 (8): 635

科室
- - 订阅+
  - 更多科室
工具
服务